Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06333652
PHASE2
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
The researchers are testing a medication named ravulizumab for the treatment of severe preeclampsia and Hemolysis, Elevated Liver enzymes, Low Platelets (HELLP) syndrome.
Official title: Clinical Trial on the Use of Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
14
Start Date
2026-03-01
Completion Date
2028-12-31
Last Updated
2025-11-12
Healthy Volunteers
No
Conditions
Interventions
DRUG
Ravulizumab
Intravenous infusion 100 mg/ml
Locations (1)
Mayo Clinic Minnesota
Rochester, Minnesota, United States